SNDL (NASDAQ:SNDL) Posts Quarterly Earnings Results

SNDL (NASDAQ:SNDL) posted its quarterly earnings results on Thursday. The company reported $0.03 earnings per share for the quarter, topping the consensus estimate of $0.01 by $0.02, reports. SNDL had a negative return on equity of 8.28% and a negative net margin of 9.66%.The company had revenue of $183.87 million during the quarter, compared to the consensus estimate of $257.97 million.

Here are the key takeaways from SNDL’s conference call:

• SNDL more than doubled annual free cash flow to CAD 18 million in 2025 and reported record full‑year net revenue, gross profit, adjusted operating income, and free cash flow, citing disciplined working capital and operational improvements.
• The company achieved its first-ever positive full‑year adjusted operating income and a record quarterly adjusted operating income (CAD 12.8M), driven by gross margin expansion (120 bps full year) and G&A/store productivity initiatives.
• Revenue pressure emerged in Q4 with net revenue down 2% YoY (CAD 252M) as market slowdowns in liquor (~3% decline) and a late‑2025 cannabis deceleration weighed on same‑store sales despite share gains.
• SNDL entered 2026 with a strong balance sheet—no debt and over CAD 250 million in unrestricted cash—used for higher capex (≈+50% YoY) to open stores, the first stage of the Cost Cannabis acquisition, and 15.1M shares repurchased since Q4 2024.
• U.S. portfolio exposure has been simplified to Parallel and Skymint, with management expecting foreclosure/receivership resolutions (likely Q2 2026) that could repatriate capital but retain execution and timing risk.

SNDL Price Performance

NASDAQ SNDL traded down $0.05 during trading on Friday, reaching $1.52. The company’s stock had a trading volume of 885,190 shares, compared to its average volume of 1,467,785. The firm has a fifty day moving average of $1.57 and a 200 day moving average of $1.94. SNDL has a one year low of $1.15 and a one year high of $2.89. The stock has a market capitalization of $389.96 million, a PE ratio of -5.83 and a beta of 0.73. The company has a debt-to-equity ratio of 0.11, a current ratio of 5.04 and a quick ratio of 3.54.

Key SNDL News

Here are the key news stories impacting SNDL this week:

• Positive Sentiment: EPS beat and improving profitability — SNDL reported $0.03 EPS vs. consensus $0.01 and showed a swing to operating income for the quarter and record full‑year gross profit, supporting a thesis of margin recovery. MarketBeat Earnings
• Positive Sentiment: Strong cash generation and balance sheet — The company reported positive free cash flow and >$250M cash with no debt, giving flexibility for M&A or continued buybacks (management has repurchased millions of shares). GlobeNewswire Release
• Positive Sentiment: Record full‑year revenue and gross profit — Management highlighted a record $946.4M in 2025 net revenue and all‑time gross profit, driven by cannabis segment growth, which supports longer‑term recovery narratives. Quiver Quant Summary
• Neutral Sentiment: Mixed retail trends — Cannabis same‑store sales improved full‑year, but Liquor Retail saw a Q4 same‑store sales decline (~4%), leaving near‑term retail growth uneven. Segment Details (GlobeNewswire)
• Neutral Sentiment: Market initially shrugged revenue miss — Headlines noted shares rose intraday after the beat and positive commentary, suggesting investors are parsing quality of earnings over headline revenue. MSN Coverage
• Negative Sentiment: Revenue missed Street estimates — Quarterly revenue came in materially below consensus ($183.9M vs. $258.0M est. in some reports), which can pressure short‑term sentiment despite an EPS beat. Revenue Miss Details
• Negative Sentiment: Investment & restructuring uncertainty — Progress on SunStream/Parallel/Skymint restructurings and recovery of certain investee notes is uncertain and timeline‑dependent (legal and regulatory milestones into 2026–2027), posing execution and recovery risk. Investments & Restructuring
• Negative Sentiment: Retail softness and guidance risk — Liquor segment softness and a lower-than-expected top line increase the risk that analysts trim near‑term sales/earnings forecasts, which can weigh on the stock. Quiver on Retail Trends

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of SNDL in a research note on Thursday, January 22nd. One research analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $4.50.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of SNDL. Mackenzie Financial Corp lifted its position in SNDL by 33.5% during the fourth quarter. Mackenzie Financial Corp now owns 336,271 shares of the company’s stock valued at $554,000 after purchasing an additional 84,387 shares during the last quarter. XTX Topco Ltd lifted its holdings in shares of SNDL by 295.6% during the 4th quarter. XTX Topco Ltd now owns 83,988 shares of the company’s stock worth $139,000 after acquiring an additional 62,758 shares during the last quarter. Oxford Asset Management LLP purchased a new position in SNDL in the fourth quarter worth $147,000. Millennium Management LLC increased its stake in SNDL by 120.1% in the fourth quarter. Millennium Management LLC now owns 1,156,161 shares of the company’s stock valued at $1,919,000 after acquiring an additional 630,870 shares during the last quarter. Finally, Man Group plc raised its position in SNDL by 14.4% during the fourth quarter. Man Group plc now owns 530,328 shares of the company’s stock valued at $880,000 after purchasing an additional 66,740 shares in the last quarter.

SNDL Company Profile

SNDL Inc, formerly known as Sundial Growers Inc, is a Canada-based consumer packaged goods company focused on the production, manufacturing and distribution of cannabis products. Headquartered in Calgary, Alberta, SNDL operates multiple cultivation and processing facilities across Canada, including indoor and hybrid greenhouses in British Columbia and Ontario. The company serves both adult-use and medical cannabis markets, supplying provincial distributors as well as operating through its own wholesale and retail networks.

The company’s product portfolio spans dried flower, pre-rolls, vape cartridges, cannabis oils, edibles and infused beverages under a variety of in-house brands.